- Global Pharma News & Resources

Eubiotics Market Growth Over The Forecast Period 2028

Eubiotics are the products that are used to maintain the optimal balance of microflora. Eubiotics help in proper nutrient absorption which is required for normal working of the animal body. Increase in demand for animal protein products coupled with ban on the use of antibiotics are the main driving forces for the growth of eubiotics market.

To get more insights, visit:

Product segment includes prebiotics, probiotics, organic acids, and essential oils. Organic acids are estimated to be one of the major product segment in global eubiotics market. Organic acids are an effective solution in addressing hygiene and feed quality issues.

Applications segment includes gut health, yield, immunity, and others. Immunity application segment is expected to grow over the forecast period. Increasing frequency of diseases occurrence in animals has boosted the demand for eubiotics. By altering the gut microflora, eubiotics enhances the immunity of the animals.

Livestock segment includes poultry, swine, aquatic, and ruminants. Poultry is expected to be largest livestock segment in the global eubiotics market. Increasing demand for poultry meat and products such as eggs is expected to drive the market growth. Eubiotics helps in increasing the yield and improve the immunity of the animals.

Based on the region the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific is estimated to be the fastest growing region in terms of revenue. Presence of emerging economies in the region namely China, India, and Indonesia is expected to fuel the market growth in the region. Changing lifestyle along with rising disposable income of the people in the region is expected have a positive impact on the market growth over the forecast period. Increasing meat consumption in the region is anticipated to drive the market growth.

For sample copy of the report, please click:

Key players operating in the global eubiotics market include Koninklijke DSM N.V., BASF SE, Novus International, MSPrebiotics Inc., E.I. Du Pont De Nemours and Company, Nebraska Cultures Inc., Advanced BioNutrition Corp, Calpis Co., Ltd., Kemin Industries Inc., and Chr. Hansen Holding A/S.

Editor Details

Last Updated: 24-Feb-2019